Clinical Trials Directory

Trials / Unknown

UnknownNCT01983215

Effects of Prevena Therapy on Obese and or Diabetic Patients With Surgical Groin Sites

EFFECTS OF PREVENA THERAPY ON REDUCTION OF GROIN SURGICAL SITE INFECTIONS IN OBESE PATIENTS UNDERGOING VASCULAR SURGERY

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
276 (actual)
Sponsor
Dr. Jean E. Starr, MD · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to determine the effects of Prevena therapy on decreasing groin surgical site infections in patients who are obese and /or diabetic having vascular surgery.

Detailed description

Patients who are obese and/or diabetic may have poor surgical healing and infection rates higher. The PREVENA therapy will be used to evaluate possible reduction of infection rates in this patient population

Conditions

Interventions

TypeNameDescription
DEVICEPrevena vac

Timeline

Start date
2013-04-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2013-11-13
Last updated
2017-01-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01983215. Inclusion in this directory is not an endorsement.